CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $206,000 | -37.8% | 8,316 | -54.9% | 0.03% | -43.6% |
| Q4 2018 | $331,000 | -38.8% | 18,432 | 0.0% | 0.06% | -30.4% |
| Q3 2018 | $541,000 | -35.4% | 18,432 | 0.0% | 0.08% | -39.2% |
| Q2 2018 | $838,000 | +33.7% | 18,432 | +55.2% | 0.13% | -5.1% |
| Q1 2018 | $627,000 | -22.4% | 11,880 | 0.0% | 0.14% | -14.9% |
| Q4 2017 | $808,000 | -17.5% | 11,880 | 0.0% | 0.16% | +3.9% |
| Q3 2017 | $979,000 | +182.9% | 11,880 | +221.3% | 0.16% | +112.3% |
| Q2 2017 | $346,000 | +47.2% | 3,697 | 0.0% | 0.07% | +46.0% |
| Q1 2017 | $235,000 | – | 3,697 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |